Free Information Kit

Learn more about living with lupus and treatment with BENLYSTA

Already taking BENLYSTA?

Get ongoing support for your treatment journey.

Expand to watch videos from
real lupus patients taking BENLYSTA.

Testimonials

Browse the full library of videos about BENLYSTA, from patient stories to answers from a rheumatologist. GSK sponsors ambassadors for BENLYSTA and pays them for their time and expense in sharing their experiences. Individual results may vary. Check back for even more videos in the future.

My Journey with BENLYSTA

We meet Michelle, Susan and Morgan, three women living with lupus and being treated with BENLYSTA. They talk candidly about themselves, sharing their own experiences, thoughts and concerns. They also offer advice for other lupus patients who are also being treated with BENLYSTA.Watch Now

About Me and Facing My Diagnosis

Michelle, Morgan and Susan talk about themselves and their reactions to finally getting their lupus diagnosis.

Watch Now

Considering BENLYSTA

Susan, Morgan and Michelle discuss how they felt about the possibility of receiving treatments with BENLYSTA.

Watch Now

The Infusion Experience

Morgan, Michelle and Susan describe the infusion process and provide helpful tips for passing the time.

Watch Now

Support for BENLYSTA & Advice for Other Lupus Patients

Michelle, Susan and Morgan offer words of advice for other people living with lupus.

Watch Now

About BENLYSTA

Lacy, Sheba, Max, and Karen talk about their experiences adding BENLYSTA to their lupus treatments.

Watch Now

Infusions

Karen, Lacy, Katrina, and Sheba recall how they felt during their first infusion of BENLYSTA.

Watch Now

Working with Your Healthcare Team

Renee, Lacy, and Sheba discuss their relationships with their healthcare teams and the importance of communication.

Watch Now

What is Lupus?

Learn about the basics of lupus and how it affects the immune system.

Watch Now

Increase the understanding

Help people not living with lupus to understand lupus

What Is BENLYSTA?

BENLYSTA is a prescription medication used to treat adults with active systemic lupus erythematosus (SLE or lupus) who are receiving other lupus medicines.

It is not known if BENLYSTA is safe and effective in people with severe active lupus nephritis or severe active central nervous system lupus, and it has not been studied in combination with other biologics or intravenous cyclophosphamide. Use of BENLYSTA is not recommended in these situations.

Important Safety Information

The most important information to know about BENLYSTA:

BENLYSTA can cause serious side effects. Some of these side effects may cause death. It is not known if BENLYSTA causes these serious side effects.

Important Safety Information

The most important information to know about BENLYSTA:

BENLYSTA can cause serious side effects. Some of these side effects may cause death. It is not known if BENLYSTA causes these serious side effects.

Tell your healthcare professional right away if you have any of the symptoms listed below while receiving BENLYSTA

Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA.

Before receiving BENLYSTA also discuss with your healthcare professional if you:

Women of childbearing age should use adequate birth control measures while taking BENLYSTA and for at least four months after their final treatment with BENLYSTA.

Remember to tell your healthcare professional about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.

Possible side effects of BENLYSTA

The most common side effects of BENLYSTA include:

Tell your healthcare professional if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of BENLYSTA. For more information, ask your healthcare professional.

Other Important Information

In 2 of 3 studies, fewer blacks/African Americans who received BENLYSTA responded to treatment compared to blacks/African Americans who did not receive BENLYSTA. Therefore, caution should be used when considering treatment with BENLYSTA in blacks/African Americans. It is important to discuss with your healthcare professional whether BENLYSTA is right for you. A clinical trial is ongoing to study BENLYSTA specifically in blacks/African Americans with lupus.


For more information, call the BENLYSTA® Gateway at 1-877-4-BENLYSTA (1-877-423-6597)
Monday through Friday, 8 AM to 8 PM Eastern Time.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.